Regeneron Pharmaceuticals (REGN) is down more than -17% to lead losers in the S&P 500 after its itepekimab, an experimental drug jointly developed with Sanofi for chronic obstructive pulmonary disease ...

Dr Sushil Kumar Sharma Each year on May 31, the World Health Organization (WHO) marks World No Tobacco Day to raise awareness ...

Facing erosion of its mighty Eylea (aflibercept) franchise and near-term loss of exclusivity with Dupixent (dupilumab), Regeneron Pharmaceuticals Inc. took a blow as one of two phase III trials with ...

In recent years, high ozone levels have been detected at Chatfield State Park, South Table Mountain in Golden, Boulder ...